NASDAQ:INBS Intelligent Bio Solutions (INBS) Stock Price, News & Analysis $1.80 -0.03 (-1.64%) As of 12:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Intelligent Bio Solutions Stock (NASDAQ:INBS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get INBS alerts:Sign Up Key Stats Today's Range$1.75▼$1.8550-Day Range$1.15▼$1.9852-Week Range$1.00▼$3.00Volume85,952 shsAverage Volume559,896 shsMarket Capitalization$12.44 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Read More Intelligent Bio Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks8th Percentile Overall ScoreINBS MarketRank™: Intelligent Bio Solutions scored higher than 8% of companies evaluated by MarketBeat, and ranked 919th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Intelligent Bio Solutions. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Intelligent Bio Solutions are expected to grow in the coming year, from ($1.25) to $0.35 per share.Price to Book Value per Share RatioIntelligent Bio Solutions has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Intelligent Bio Solutions' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.99% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in Intelligent Bio Solutions has recently increased by 15.95%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIntelligent Bio Solutions does not currently pay a dividend.Dividend GrowthIntelligent Bio Solutions does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.99% of the float of Intelligent Bio Solutions has been sold short.Short Interest Ratio / Days to CoverIntelligent Bio Solutions has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in Intelligent Bio Solutions has recently increased by 15.95%, indicating that investor sentiment is decreasing significantly. News and Social Media2.6 / 5News Sentiment0.64 News SentimentIntelligent Bio Solutions has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Intelligent Bio Solutions this week, compared to 2 articles on an average week.Search Interest3 people have searched for INBS on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Intelligent Bio Solutions insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.54% of the stock of Intelligent Bio Solutions is held by insiders.Percentage Held by InstitutionsOnly 32.97% of the stock of Intelligent Bio Solutions is held by institutions.Read more about Intelligent Bio Solutions' insider trading history. Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address INBS Stock News HeadlinesIntelligent Bio Solutions Inc. - INBS | Barron'sJune 27, 2025 | barrons.comIntelligent Bio Solutions expands drug screening in ScandinaviaJune 26, 2025 | investing.comTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…July 3 at 2:00 AM | Crypto 101 Media (Ad)Intelligent Bio Solutions Inc. and Spjotgard Partner to Advance Fingerprint Drug Screening in Scandinavia - NasdaqJune 26, 2025 | nasdaq.comIntelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across ScandinaviaJune 25, 2025 | globenewswire.comIntelligent Bio Solutions Inc. Partners with Managed Waste Service to Implement Innovative Drug Screening Technology in New South Wales OperationsJune 20, 2025 | nasdaq.comIntelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC ExpansionJune 18, 2025 | globenewswire.comIntelligent Bio Solutions (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire PodcastJune 17, 2025 | theglobeandmail.comSee More Headlines INBS Stock Analysis - Frequently Asked Questions How have INBS shares performed this year? Intelligent Bio Solutions' stock was trading at $1.40 on January 1st, 2025. Since then, INBS stock has increased by 29.6% and is now trading at $1.8150. View the best growth stocks for 2025 here. How were Intelligent Bio Solutions' earnings last quarter? Intelligent Bio Solutions Inc. (NASDAQ:INBS) posted its earnings results on Thursday, February, 13th. The company reported ($0.50) earnings per share (EPS) for the quarter. The business had revenue of $610 billion for the quarter. Intelligent Bio Solutions had a negative trailing twelve-month return on equity of 176.55% and a negative net margin of 319.85%. When did Intelligent Bio Solutions' stock split? Shares of Intelligent Bio Solutions reverse split on the morning of Monday, January 29th 2024.The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Intelligent Bio Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intelligent Bio Solutions investors own include SoFi Technologies (SOFI), Plug Power (PLUG), Allarity Therapeutics (ALLR), Adial Pharmaceuticals (ADIL), AMC Entertainment (AMC), ARMOUR Residential REIT (ARR) and BIOLASE (BIOL). Company Calendar Last Earnings2/13/2025Today7/03/2025Next Earnings (Estimated)9/17/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNASDAQ:INBS CIK1725430 Webgbs.inc Phone646-828-8258FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.16 million Net Margins-319.85% Pretax Margin-320.94% Return on Equity-176.55% Return on Assets-93.89% Debt Debt-to-Equity RatioN/A Current Ratio1.12 Quick Ratio0.97 Sales & Book Value Annual Sales$3.11 million Price / Sales4.07 Cash FlowN/A Price / Cash FlowN/A Book Value$2.37 per share Price / Book0.77Miscellaneous Outstanding Shares6,910,000Free Float6,804,000Market Cap$12.65 million OptionableNot Optionable Beta4.60 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NASDAQ:INBS) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intelligent Bio Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.